cbdMD, Inc. (NYSEAM:YCBD) acquired assets of Gaia Botanicals, LLC for $1 million on January 12, 2026. bdMD acquired the Bluebird Botanicals brand, its online CBD marketplace (bluebirdbotanicals.com), related trademarks, existing inventory, and intellectual property (including patented-process technologies and regulatory compliance documentation). The consideration consists of 0.43 million common equity of cbdMD, Inc. to be issued for assets of Gaia Botanicals, LLC and 0.53 million common equity in earnout basis which shall be issued to Bluebird on or before the 60th day following the twelve month anniversary of the Closing Date if the revenue targets of $2.9 million are met. 0.43 million shares if revenue targets of $2.7 million are met, 0.32 million if revenue targets of $2.5 million are met, 0.19 million if revenue targets of $2.3 million are met, 0.08 million if revenue targets of $2 million are met and no earnout below that. Both the initial shares and any future earnout shares are subject to a 180-day lock-up period starting from the effective date. Following the lock-up, the shares are subject to "dribble-out" rules, which limit the volume of shares Gaia can sell into the public market over a subsequent 365-day period (limited to 100,000 shares per quarter).

cbdMD, Inc. shall provide employment to all five employees of Gaia Botanicals.
cbdMD, Inc. (NYSEAM:YCBD) completed the acquisition of assets of Gaia Botanicals, LLC on January 12, 2026.